.
HCQ ups death risk, warns Indian-origin researcher in Lancet study
HCQ ups death risk, warns Indian-origin researcher in Lancet study

Photo Credit: IANS

IANSLive

New York, May 23 (IANS) A significant observational study led by Professor Mandeep R. Mehra, executive director of the Brigham and Women's Hospital Center for Advanced Heart Disease in Boston, has claimed that treatment with antimalarial drug chloroquine or hydroxychloroquine (taken with or without antibiotics azithromycin or clarithromycin) offers no benefit for patients with Covid-19.

To get full access of the story, click here to subscribe to IANS News Service

© 2020 IANS India Private Limited. All Rights Reserved.
The reproduction of the story/photograph in any form will be liable for legal action.

For news, views and gossips, follow IANS at Twitter.

Update: 23-May-2020

RELATED TOPICS

SCIENCE & TECHNOLOGY



© 2020 IANS India Private Limited.
Don't forget to bookmark us! (CTRL-D)
Site designed by IANS